24 September 2020 - The chief executive of AstraZeneca has said the public must trust that multiple regulators will review ...
22 September 2020 - The level of trust in health economics and outcomes research studies has been an on-going concern owing ...
1 September 2020 - Less than one week in and the agenda for the next scheduled PBAC meeting has already been ...
25 August 2020 - Agenda items are revised with no indication of what has been changed. ...
20 August 2020 - A proposed change to the new health insurance law that seeks to keep drug prices under lock ...
6 August 2020 - Amid growing clamour for more transparency from the pharmaceutical industry, Italy has become the first country ...
5 August 2020 - A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel ...
28 July 2020 - Indicative 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure have now been ...
23 July 2020 - The PBAC has made a statement outlining its support for measures to improve the transparency of ...
25 June 2020 - The summary of price disclosure price reductions for the October 2020 Cycle has now been published. ...
18 June 2020 - A US court has ruled against a move by President Donald Trump's administration to try to bring ...
1 June 2020 - In a response to officials at Germany’s IQWiG and the Cochrane Collaboration, EMA Executive Director Guido ...
14 May 2020 - On 4 February 2020, the Secretary of the US Department of Health and Human Services (DHHS) determined ...
11 May 2020 - Australia’s secretive drug approval system gives what some believe is an unfair advantage to rival drug companies. ...
1 May 2020 - Published on Wednesday and revised (with no notification) by Friday. ...